- Dietary Carbohydrates
- Accession Number
Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes (FABACEAE), tubers, etc. (From Claudio & Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277)
Drug Drug Description Inulin Historically used in an important medical test of renal function, specifically a measure of glomerular filtration rate. Sometimes used to help relieve symptoms of diabetes mellitus - a condition characterised... Betadex Not Available IT-101 Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors. Sugammadex A modified gamma cyclodextrin used to reverse neuromuscular blockade induced by vecuronium bromide and rocuronium bromide which are agents used for anesthesia. Dextrin 2-sulfate Investigated for use/treatment in HIV prevention. Hydroxyethyl Starch A plasma volume substitute used to treat and prevent hypovolemia. Pentastarch A plasma volume expander used as an adjunct in the management of shock due to hemorrhage, surgery, sepsis, burns or other trauma. Starch, corn Corn starch refers to the starch extracted from the corn grain that is commonly used as a food ingredient and chemical additive. Starch is any of a group of polysaccharides... Brexanolone Brexanolone is a synthetic neuroactive steroid gamma-aminobutyric acid A (GABA(a)) receptor positive modulator indicated for the treatment of postpartum depression (PPD) in adult women [FDA Label][A176080, A176083, F4063, F4066, F4072]. Amylopectin Amylopectin is under investigation in clinical trial NCT01708694 (Role of Slowly Digesible Starch on Diabetes Risk Factors). Amylose Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial). Hydroxypropyl betadex Hydroxypropyl betadex is under investigation in clinical trial NCT03471143 (Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C).
- Drugs & Drug Targets
Drug Target Type Inulin Cycloinulo-oligosaccharide fructanotransferase target Betadex Neopullulanase 2 target Betadex Maltose-binding periplasmic protein target Betadex Maltogenic amylase target Brexanolone GABA(A) Receptor target Brexanolone Aldose reductase enzyme